Moloney Securities Asset Management, LLC Gilead Sciences, Inc. Transaction History
Moloney Securities Asset Management, LLC
- $723 Million
- Q2 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 2,367 shares of GILD stock, worth $283,542. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,367
Previous 2,531
6.48%
Holding current value
$283,542
Previous $283,000
7.42%
% of portfolio
0.04%
Previous 0.04%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,347Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.09 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.55 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.5 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...